Fibroblast Growth Factor 15/19 in Hepatocarcinogenesis

Background: Advanced hepatocellular carcinoma (HCC) is a neoplastic disease with a very bad prognosis and increasing worldwide incidence. HCCs are resistant to conventional chemotherapy and the multikinase inhibitor sorafenib is the only agent that has shown some clinical efficacy. It is therefore i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Digestive diseases (Basel) 2017-01, Vol.35 (3), p.158-165
Hauptverfasser: Alvarez-Sola, Gloria, Uriarte, Iker, Latasa, M. Ujue, Urtasun, Raquel, Bárcena-Varela, Marina, Elizalde, Maria, Jiménez, Maddalen, Rodriguez-Ortigosa, Carlos M., Corrales, Fernando J., Fernández-Barrena, Maite G., Berasain, Carmen, Avila, Matías A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!